Dunford Alexander, Keramida Georgia, Singh Nitasha, Aplin Mark, Peters A Michael
Brighton and Sussex University Hospitals NHS Trust.
Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, Brighton, UK.
Nucl Med Commun. 2019 Mar;40(3):212-218. doi: 10.1097/MNM.0000000000000968.
Hepatic steatosis is associated with insulin resistance and hyperinsulinaemia. Insulin stimulates hepatic glucokinase, even in insulin resistance, so hepatic glucose uptake is increased in hepatic steatosis. The study hypothesis was that hepatic glucose uptake is also influenced locally by fat, the hepatic distribution of which is heterogeneous.
Sixty patients undergoing PET/CT using fluorine-18-fluorodeoxyglucose (F-FDG) had dynamic imaging of the liver for 30 min after injection before undergoing whole-body PET/CT at 60 min after injection. Hepatic F-FDG uptake was measured using Gjedde-Patlak-Rutland graphical analysis. Plot gradient (Ki), which represents hepatic blood clearance of F-FDG to phosphorylation, was normalized to intercept [V(0)], which represents the hepatic F-FDG distribution volume. The 60 min computed tomography (CT) was co-registered on to each of the 30 dynamic PET frames. This failed in 20 patients. A further seven patients with lymphoma and three with hepatic metastases were excluded. Within transaxial sections, the liver was divided into small regions of interest (ROIs) of 5×5 pixels each in sections of 5 mm (range: 118-586 ROIs/liver). CT density and Ki/V(0) were measured in each ROI.
Throughout the 25-pixel ROIs in the individual liver, CT density and Ki/V(0) showed a significant negative correlation in 15/30 patients. It was significantly positive in only three (P=0.01). In some patients, parametric imaging showed regional concordance between Ki/V(0) and hepatic fat, identified as reduced CT density.
In addition to systemic influences, hepatic glucose uptake is regionally linked to the distribution of hepatic fat. Increased metabolism could be the cause or result of local fat deposition.
肝脂肪变性与胰岛素抵抗及高胰岛素血症相关。胰岛素可刺激肝葡萄糖激酶,即使在胰岛素抵抗状态下亦是如此,因此肝脂肪变性时肝葡萄糖摄取增加。本研究的假设是,肝葡萄糖摄取也受局部脂肪的影响,而肝内脂肪分布不均一。
60例接受使用氟-18-氟脱氧葡萄糖(F-FDG)的PET/CT检查的患者,在注射后60分钟进行全身PET/CT检查前,先对肝脏进行30分钟的动态成像。使用Gjedde-Patlak-Rutland图像分析方法测量肝脏F-FDG摄取。代表F-FDG肝血清除至磷酸化的曲线斜率(Ki),以代表肝脏F-FDG分布容积的截距[V(0)]进行标准化。将60分钟的计算机断层扫描(CT)与30个动态PET图像帧中的每一个进行配准。20例患者未成功配准。另外排除7例淋巴瘤患者和3例肝转移患者。在横断面内,将肝脏在5毫米的切片中分成每个5×5像素的小感兴趣区(ROI)(范围:118 - 586个ROI/肝脏)。在每个ROI中测量CT密度和Ki/V(0)。
在个体肝脏的整个25像素ROI中,CT密度和Ki/V(0)在15/30例患者中呈显著负相关。仅3例呈显著正相关(P = 0.01)。在一些患者中,参数成像显示Ki/V(0)与肝脂肪之间存在区域一致性,肝脂肪表现为CT密度降低。
除了全身影响外,肝葡萄糖摄取在区域上与肝脂肪分布相关。代谢增加可能是局部脂肪沉积的原因或结果。